1. Rising Demand for Diagnostic Tools in Malaria-Endemic Regions Driving the Market
In the recent times, the World Health Organization (WHO) has taken various initiatives with a renewed interest and commitment, to eliminate the incidence of malaria diseases in nearly 35 endemic countries, by 2030. There has been a rising interest in malaria, as WHO reports indicate that in 2016, around 216 million cases of malaria were reported in 91 countries, an annual increase of about five million cases, with the highest burden in developing regions, such as Africa and South Asia. According to two recent reports by Unitaid, a non-profit organization, there is a rising demand for malaria diagnostics and treatment, with over 400 million treatments. Robust scale up is anticipated to be required for rapid malaria diagnostic tests, with an increasing preference for novel molecular diagnostic tools that offer high throughput and effective performance in laboratories, for the elimination of malaria. Thus, the rising demand is a crucial factor responsible for the growth of the malaria diagnostic market.
2. Significant Growth of Rapid Diagnostic Tests (RDTs) Expected to Lead the Market
Malaria rapid diagnostic tests play a critical role in the management of malaria, as they have revolutionized the diagnosis and are recording an increasing demand. The high demand can also be attributed to the ability of these tests to produce results within 15 minutes, using a single drop of the patient’s blood. Since 2010, the WHO has strongly endorsed rapid malaria tests across several countries in Africa, to reduce the overuse of anti-malarial drugs. In 2017, a positive impact has been observed, with more than 300 million RDTs for malaria reportedly being in use each year. Further, these tests are yet to be explored well in several emerging countries, such as Uganda, Sudan, and the Middle Eastern countries, which provides the companies significant growth prospects during the forecast period, for using RDT technologies.
3. Asia-Pacific to Offer Considerable Growth Prospects for the Malaria Diagnostics Market
The market studied is expected to witness an exponentially high demand over the forecast period and Asia-Pacific is expected to register the fastest growth during the forecast period. The Southeast Asian countries record the highest demand for malaria diagnostic testing, with a robust demand to provide access to these tests across a large patient pool in developing countries. The WHO estimates that India accounts for more than 75% of the total cases of malaria in Southeast Asia. Therefore, India is a part of Asia-Pacific Leaders Malaria Alliance Secretariat (APLMA), which aims to eliminate malaria in South Asian countries, by 2030. The growing economies, government initiatives, collaborations of multinational companies with domestic players, and healthy participation of private companies make this region a lucrative segment for the growth of the malaria diagnostics market, during the forecast period.
4. Leading Companies in the Market Studied
The report also examines the role of the leading players involved in the industry. Some of the key players listed in the study are:
- Access Bio Inc.
- Biomerieux SA
- Bio-Rad Laboratories Inc.
- Novartis AG
- Danaher (Beckman Coulter)
- Premier Medical Corporation Pvt Ltd
- Siemens Healthineers
- Thermo Fisher Scientific
About the Malaria Diagnostic Market
The Mordor Intelligence report estimates indicate that the global malaria diagnostics market is anticipated to register a CAGR of about 4.5% over the forecast period of 2018-2023, with an upsurge in the demand for technological advancements and diagnostic tools.
Mordor Intelligence is a market intelligence and advisory firm operating in 14 industry segments, serving over 600 clients worldwide.